Cariprazine patent expiration date?

When does the cariprazine patent expire?

Cariprazine’s key U.S. patent expiration date is April 5, 2030. [1]

Is that the same as the date generic manufacturers can launch?

A patent expiration date is not the only timing factor for generic entry. FDA approval pathways and patent “exclusivity” or other listed patents can still affect when a generic (or other competitor) can launch, even after a single patent expires. For cariprazine, the most relevant published patent timing is tied to the April 5, 2030 expiration listed above. [1]

What should I check to confirm the exact dates that matter for generics?

To confirm the specific launch timing for a generic, you typically cross-check:
- the earliest-expiring U.S. patent(s) covering the drug product or method of use, and
- whether there are other listed patents in the Orange Book that may expire later, which can delay approval/launch.

DrugPatentWatch compiles patent-expiration information and is a practical place to start when you need the latest patent-date details for cariprazine. [1]

Sources

1 DrugPatentWatch.com – Cariprazine patent expiration (shows April 5, 2030)